Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Evgen Pharma Plc | 8EV | Jan 31, 2025 | 0.00 | 0.00 |
EVI Industries, Inc. | 2YE | Jan 31, 2025 | 16.30 | +3.82 |
EVION GROUP NL | BAPA | Jan 31, 2025 | 0.01 | +4.55 |
Eviso SPA | 6Z8 | Jan 31, 2025 | 7.92 | 0.00 |
EVLI OYJ B | V6O | Jan 31, 2025 | 18.50 | +0.27 |
EVN AG | EVN | Jan 31, 2025 | 22.90 | -0.43 |
Evolent Health, Inc Class A | 9EH | Jan 31, 2025 | 10.20 | +2.51 |
Evolus, Inc. | EVL | Jan 31, 2025 | 13.50 | -2.17 |
Evolution | E3G1 | Jan 31, 2025 | 75.10 | +4.45 |
Evolution Energy Minerals Ltd | P77 | Jan 31, 2025 | 0.01 | 0.00 |
Evolution Mining Limited | WE7 | Jan 31, 2025 | 3.37 | -2.43 |
Evolution Petroleum Corporation, Inc. | EP7 | Jan 31, 2025 | 5.20 | -0.95 |
EVONIK INDS AG American Depositary Receipts - Unsponsored ( | EVKA | Jan 31, 2025 | 8.75 | +1.74 |
Evonik Industries AG | EVK | Jan 31, 2025 | 18.19 | -0.57 |
Evotec SE | EVT | Jan 31, 2025 | 8.53 | +0.29 |
EVOTEC SE ADR/2 O.N. | EVTA | Jan 31, 2025 | 4.38 | +12.31 |
EVS Broadcast Equipment SA | 5E1 | Jan 31, 2025 | 30.40 | +1.50 |
Exact Sciences Corporation | EXK | Jan 31, 2025 | 53.75 | +2.24 |
EXACT Therapeutics | 56F | Jan 31, 2025 | 0.23 | +0.86 |
Exagen Inc. | E08A | Jan 31, 2025 | 3.88 | +1.04 |
EXASOL AG NA O.N. | EXL | Jan 31, 2025 | 3.11 | +14.34 |
Excellence SA | 8XY | Jan 31, 2025 | 0.03 | +2.07 |
Excellon Resources Inc | E4X2 | Jan 31, 2025 | 0.06 | +3.60 |
Exchange Income Corp | 0ON | Jan 31, 2025 | 37.40 | +0.54 |
Exclusive Networks SA | 97K | Jan 31, 2025 | 18.92 | -0.21 |
EXCO Technologies Ltd. | 3XT | Jan 31, 2025 | 4.80 | +0.42 |
Exedy Corporation | 64M | Jan 31, 2025 | 28.20 | +7.63 |
EXEL COMPOSITES OYJ | 8TY | Jan 31, 2025 | 0.32 | +5.21 |
Exel Industries | 8YK | Jan 31, 2025 | 43.60 | +2.11 |
Exelixis, Inc. | EX9 | Jan 31, 2025 | 31.43 | +0.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.